Y Wang, KJ Szretter, W Vermi, S Gilfillan, C Rossini, M Cella, AD Barrow, MS Diamond, M Colonna. (2012) "IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia." Nat Immunol 13. 753-60 PMID: 22729249 DOI: 10.1038/ni.2360 | Abstract and Keywords
C Penaranda, W Kuswanto, J Hofmann, R Kenefeck, P Narendran, LS Walker, JA Bluestone, AK Abbas, H Dooms. (2012) "IL-7 receptor blockade reverses autoimmune diabetes by promoting inhibition of effector/memory T cells." Proc Natl Acad Sci U S A 109. 12668-73 PMID: 22733744 DOI: 10.1073/pnas.1203692109 | Abstract and Keywords
S Remakus, D Rubio, X Ma, A Sette, LJ Sigal. (2012) "Memory CD8+ T cells specific for a single immunodominant or subdominant determinant induced by peptide-dendritic cell immunization protect from an acute lethal viral disease." J Virol 86. 9748-59 PMID: 22740418 DOI: 10.1128/JVI.00981-12 | Abstract and Keywords
YA Aldhamen, SS Seregin, NJ Schuldt, DP Rastall, CJ Liu, S Godbehere, A Amalfitano. (2012) "Vaccines expressing the innate immune modulator EAT-2 elicit potent effector memory T lymphocyte responses despite pre-existing vaccine immunity." J Immunol 189. 1349-59 PMID: 22745373 DOI: 10.4049/jimmunol.1200736 | Abstract and Keywords
YY Lin, ME Jones-Mason, M Inoue, A Lasorella, A Iavarone, QJ Li, ML Shinohara, Y Zhuang. (2012) "Transcriptional regulator Id2 is required for the CD4 T cell immune response in the development of experimental autoimmune encephalomyelitis." J Immunol 189. 1400-5 PMID: 22745378 DOI: 10.4049/jimmunol.1200491 | Abstract and Keywords
Y Zhou, B Callendret, D Xu, KM Brasky, Z Feng, LL Hensley, J Guedj, AS Perelson, SM Lemon, RE Lanford, CM Walker. (2012) "Dominance of the CD4(+) T helper cell response during acute resolving hepatitis A virus infection." J Exp Med 209. 1481-92 PMID: 22753925 DOI: 10.1084/jem.20111906 | Abstract and Keywords
J Kwun, BC Oh, AC Gibby, R Ruhil, VT Lu, DW Kim, EK Page, OP Bulut, MQ Song, AB Farris, AD Kirk, SJ Knechtle, NN Iwakoshi. (2012) "Patterns of de novo allo B cells and antibody formation in chronic cardiac allograft rejection after alemtuzumab treatment." Am J Transplant 12. 2641-51 PMID: 22759336 DOI: 10.1111/j.1600-6143.2012.04181.x | Abstract and Keywords